Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host

Tuberculosis

Volumn 90, Issue 2, 2010, Pages 84-93

  Torrelles, Jordi B ^a   Schlesinger, Larry S ^a  

^a Center for Microbial Interface Biology   (United States)

Author keywords

Macrophage; Mannose receptor; Mannose capped lipoarabinomannan; Trafficking; Tuberculosis

Indexed keywords

CARBOHYDRATE; LECTIN; LIPID; MANNOPROTEIN; MANNOSE; MANNOSE RECEPTOR; OLIGOSACCHARIDE;

ADAPTATION; BACTERIAL CELL WALL; BACTERIAL GENOME; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BIODIVERSITY; FOREIGN BODY; GENE SEQUENCE; GENETIC VARIABILITY; HOST; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MOLECULAR EVOLUTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PHAGOSOME; PHYLOGENY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SURVIVAL;

BACTERIAL ADHESION; CELL WALL; GENETIC VARIATION; HUMANS; LECTINS, C-TYPE; MACROPHAGES; MANNOSE-BINDING LECTINS; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; RECEPTORS, CELL SURFACE; TUBERCULOSIS;

EID: 77950595167     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.02.003     Document Type: Review

References (126)

1. Global tuberculosis control - epidemiology, strategy, financing (2009), World Health Organization, WHO Press, Geneva, Switzerland WHO/HTM/TB/2009.411
2. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu Rev Immunol 19 (2001) 93-129
3. Schlesinger L.S., Azad A.K., Torrelles J.B., Roberts E., Vergne I., and Deretic V. Determinants of phagocytosis, phagosome biogenesis and autophagy for Mycobacterium tuberculosis. In: Kaufmann S.H.E., and Britton W.J. (Eds). Handbook of tuberculosis. Immunology and cell biology (2008), Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim, Germany 1-22 Year book
4. Fenton M.J., Riley L.W., and Schlesinger L.S. Receptor-mediated recognition of Mycobacterium tuberculosis by host cells. In: Cole S.T., Eisenach K.D., McMurray D.N., and Jacobs Jr. W.R. (Eds). Tuberculosis and the tubercle bacillus (2005), ASM Press, New York 405-426 Year book
5. Lohmann-Matthes M.L., Steinmuller C., and Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 7 (1994) 1678-1689
6. Cohn Z.A., and Wiener E. The particulate hydrolases of macrophages. I. Comparative enzymology, isolation and properties. J Exp Med 118 (1963) 991-1008
7. Sorber W.A., Leake E.S., and Myrvik Q.N. Comparative densities of hydrolase-containing granules from normal and BCG-induced alveolar macrophages. Infect Immun 7 (1973) 86-92
8. Jonsson S., Musher D.M., Goree A., and Lawrence E.C. Human alveolar lining material and antibacterial defenses. Am Rev Respir Dis 133 (1986) 136-140
9. Reynolds H.Y. Bronchoalveolar lavage. Am Rev Respir Dis 135 (1987) 250-263
10. Stephenson J.D., and Shepherd V.L. Purification of the human alveolar macrophage mannose receptor. Biochem Biophys Res Commun 148 (1987) 883-889
11. Palecanda A., and Kobzik L. Receptors for unopsonized particles: the role of alveolar macrophage scavenger receptors. Curr Mol Med 1 (2001) 589-595
12. Ferguson J.S., and Schlesinger L.S. Pulmonary surfactant in innate immunity and the pathogenesis of tuberculosis. Tuber Lung Dis 80 (2000) 173-184
13. Day J., Friedman A., and Schlesinger L.S. Modeling the immune rheostat of macrophages in the lung in response to infection. Proc Natl Acad Sci USA 106 (2009) 11246-11251
14. Schlesinger L.S. The role of mononuclear phagocytes in tuberculosis (1997) 437-480
15. Ohtsubo K., and Marth J.D. Glycosylation in cellular mechanisms of health and disease. Cell 126 (2006) 855-867
16. Coutinho P.M., Stam M., Blanc E., and Henrissat B. Why are there so many carbohydrate-active enzyme-related genes in plants?. Trends Plant Sci 8 (2003) 563-565
17. Varki A. Nothing in glycobiology makes sense, except in the light of evolution. Cell 126 (2006) 841-845
18. In: Moran A., Holst O., Brennan P., and von Itzstein M. (Eds). Microbial glycobiology: structure, relevance and applications (2009), Academic Press, US 1-1020 Year book
19. Brennan P.J., and Nikaido H. The envelope of mycobacteria. Annu Rev Biochem 64 (1995) 29-63
20. Crick D.C., Brennan P.J., and McNeil M.R. The cell wall of Mycobacterium tuberculosis. In: Rom W.M., and Garay S.M. (Eds). Tuberculosis (2003), Lippincott Williams and Wilkins, Philadelphia 115-134 Year book
21. Kolattukudy P.E., Fernandes N.D., Azad A.K., Fitzmaurice A.M., and Sirakova T.D. Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria. Mol Microbiol 24 (1997) 263-270
22. Venisse A., Rivière M., Vercauteren J., and Puzo G. Structural analysis of the mannan region of lipoarabinomannan from Mycobacterium bovis BCG. Heterogeneity in phosphorylation state. J Biol Chem 270 (1995) 15012-15021
23. Nigou J., Gilleron M., and Puzo G. Lipoarabinomannans: from structure to biosynthesis. Biochimie 85 (2003) 153-166
24. Schlesinger L.S., Hull S.R., and Kaufman T.M. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol 152 (1994) 4070-4079
25. Schlesinger L.S., Kaufman T.M., Iyer S., Hull S.R., and Marciando L.K. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J Immunol 157 (1996) 4568-4575
26. Maeda N., Nigou J., Herrmann J.L., Jackson M., Amara A., Lagrange P.H., et al. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem 278 (2003) 5513-5516
27. Geijtenbeek T.B., Van Vliet S.J., Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M., Appelmelk B., et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197 (2003) 7-17
28. Strohmeier G.R., and Fenton M.J. Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microbes Infect 1 (1999) 709-717
29. Hunter S.W., and Brennan P.J. Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J Biol Chem 265 (1990) 9272-9279
30. Schlesinger L.S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 150 (1993) 2920-2930
31. Azad A.K., Torrelles J.B., and Schlesinger L.S. Mutation in the DC-SIGN cytoplasmic triacidic cluster motif markedly attenuates receptor activity for phagocytosis and endocytosis of mannose-containing ligands by human myeloid cells. J Leukoc Biol (2008)
32. Lemassu A., and Daffe M. Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis. Biochem J 297 Pt 2 (1994) 351-357
33. Chatterjee D., and Khoo K.-H. Mycobcterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8 (1998) 113-120
34. +2-dependent cell signaling. J Infect Dis 182 (2000) 240-251
35. Nigou J., Gilleron M., Rojas M., Garcia L.F., Thurnher M., and Puzo G. Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response. Microbes Infect 4 (2002) 945-953
36. Xu S., Cooper A., Sturgill-Koszycki S., Van Heyningen T., Chatterjee D., Orme I., et al. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J Immunol 153 (1994) 2568-2578
37. Prigozy T.I., Sieling P.A., Clemens D., Stewart P.L., Behar S.M., Porcelli S.A., et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6 (1997) 187-197
38. Sieling P.A., Chatterjee D., Porcelli S.A., Prigozy T.I., Mazzaccaro R.J., Soriano T., et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269 (1995) 227-230
39. Torrelles JB, Sieling PA, Brennan PJ, Modlin RL, Chatterjee D. Characterization of lipoarabinomannan isoforms of Mycobacterium tuberculosis responsible for precise recognition by CD1-restricted T cells. Tuberculosis: integrating host and pathogen biology, Keystone symposia, Taos, New Mexico: Year 2003, Abstract.
40. Kang P.B., Azad A.K., Torrelles J.B., Kaufman T.M., Beharka A., Tibesar E., et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 202 (2005) 987-999
41. Kusner D.J. Mechanisms of mycobacterial persistence in tuberculosis. Clin Immunol 114 (2005) 239-247
42. 2+/calmodulin-PI3K hVPS34 cascade. J Exp Med 198 (2003) 653-659
43. Fratti R.A., Chua J., Vergne I., and Deretic V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci US A 100 (2003) 5437-5442
44. Welin A., Winberg M.E., Abdalla H., Sarndahl E., Rasmusson B., Stendahl O., et al. Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block. Infect Immun 76 (2008) 2882-2887
45. Ilangumaran S., Arni S., Poincelet M., Theler J.M., Brennan P.J., Nasir u.D., et al. Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes. J Immunol 155 (1995) 1334-1342
46. Shabaana A.K., Kulangara K., Semac I., Parel Y., Ilangumaran S., Dharmalingam K., et al. Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling. Cell Mol Life Sci 62 (2005) 179-187
47. Gilleron M., Nigou J., Cahuzac B., and Puzo G. Structural study of the lipomannans from Mycobacterium bovis BCG: characterisation of multiacylated forms of the phosphatidyl-myo-inositol anchor. J Mol Biol 285 (1999) 2147-2160
48. Guerardel Y., Maes E., Elass E., Leroy Y., Timmerman P., Besra G.S., et al. Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1,3-mannopyranose side chains. J Biol Chem 277 (2002) 30635-30648
49. Guerardel Y., Maes E., Briken V., Chirat F., Leroy Y., Locht C., et al. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties. J Biol Chem 278 (2003) 36637-36651
50. Barnes P.F., Chatterjee D., Abrams J.S., Lu S., Wang E., Yamamura M., et al. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol 149 (1992) 541-547
51. Chan E.D., Morris K.R., Belisle J.T., Hill P., Remigio L.K., Brennan P.J., et al. Induction of inducible nitric oxide synthase-NO• by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-κB signaling pathways. Infect Immun 69 (2001) 2001-2010
52. Gilleron M., Ronet C., Mempel M., Monsarrat B., Gachelin G., and Puzo G. Acylation state of the phosphatidylinositol mannosides from Mycobcterium bovis bacillus Calmette Guerin and ability to induce granuloma and recruit natural killer T cells. J Biol Chem 276 (2001) 34896-34904
53. Torrelles J.B., Azad A.K., and Schlesinger L.S. Fine discrimination in the recognition of individula species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J Immunol 177 (2006) 1805-1816
54. Vignal C., Guerardel Y., Kremer L., Masson M., Legrand D., Mazurier J., et al. Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism. J Immunol 171 (2003) 2014-2023
55. Dao D.N., Kremer L., Guerardel Y., Molano A., Jacobs Jr. W.R., Porcelli S.A., et al. Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect Immun 72 (2004) 2067-2074
56. Gilleron M., Nigou J., Nicolle D., Quesniaux V., and Puzo G. The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2. Chem Biol 13 (2006) 39-47
57. Nigou J., Vasselon T., Ray A., Constant P., Gilleron M., Besra G.S., et al. Mannan chain length controls lipoglycans signaling via and binding to TLR2. J Immunol 180 (2008) 6696-6702
58. Khoo K.-H., Dell A., Morris H.R., Brennan P.J., and Chatterjee D. Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: Definition of a common anchor for lipomannan and lipoarabinomannan. Glycobiology 5 (1995) 117-127
59. Vergne I., Fratti R.A., Hill P.J., Chua J., Belisle J., and Deretic V. Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol Biol Cell 15 (2004) 751-760
60. Chua J., Vergne I., Master S., and Deretic V. A tale of two lipids: Mycobacterium tuberculosis phagosome maturation arrest. Curr Opin Microbiol 7 (2004) 71-77
61. Villeneuve C., Gilleron M., Maridonneau-Parini I., Daffe M., Astarie-Dequeker C., and Etienne G. Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process. J Lipid Res 46 (2005) 475-483
62. de la Salle H., Mariotti S., Angenieux C., Gilleron M., Garcia-Alles L.F., Malm D., et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 310 (2005) 1321-1324
63. Driessen N.N., Ummels R., Maaskant J.J., Gurcha S.S., Besra G.S., Ainge G.D., et al. Role of phosphatidylinositol mannosides in the interaction between mycobacteria and DC-SIGN. Infect Immun 77 (2009) 4538-4547
64. Ortalo-Magne A., Dupont M.A., Lemassu A., Andersen A.B., Gounon P., and Daffe M. Molecular composition of the outermost capsular material of the tubercle bacillus. Microbiology 141 Pt 7 (1995) 1609-1620
65. Daffe M., and Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39 (1998) 131-203
66. Schwebach J.R., Casadevall A., Schneerson R., Dai Z., Wang X., Robbins J.B., et al. Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infect Immun 69 (2001) 5671-5678
67. Ellner J.J., and Daniel T.M. Immunosuppression by mycobacterial arabinomannan. Clin Exp Immunol 35 (1979) 250-257
68. Oka H., Shiraishi Y., Sasaki H., Yoshinaga K., Emori Y., and Takei M. Antimetastatic effect of an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, Z-100, through the production of interleukin-12. Biol Pharm Bull 26 (2003) 1336-1341
69. Oka H., Sasaki H., Shiraishi Y., Emori Y., Yoshinaga K., and Takei M. Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, augments anti-tumor activities of X-ray irradiation against B16 melanoma in association with the improvement of type 1T cell responses. Biol Pharm Bull 27 (2004) 82-88
70. Wittkowski M., Mittelstadt J., Brandau S., Reiling N., Lindner B., Torrelles J., et al. Capsular arabinomannans from Mycobacterium avium with morphotype-specific structural differences but identical biological activity. J Biol Chem 282 (2007) 19103-19112
71. Espitia C., and Mancilla R. Identification, isolation and partial characterization of Mycobacterium tuberculosis glycoprotein antigens. Clin Exp Immunol 77 (1989) 378-383
72. Fifis T., Costopoulos C., Radford A.J., Bacic A., and Wood P.R. Purification and characterization of major antigens from a Mycobacterium bovis culture filtrate. Infect Immun 59 (1991) 800-807
73. Garbe T., Harris D., Vordermeier M., Lathigra R., Ivanyi J., and Young D. Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: immunological analysis and evidence of glycosylation. Infect Immun 61 (1993) 260-267
74. Young D.B., and Garbe T.R. Lipoprotein antigens of Mycobacterium tuberculosis. Res Microbiol 142 (1991) 55-65
75. Dobos K.M., Swiderek K., Khoo K.-H., Brennan P.J., and Belisle J.T. Evidence for glycosylation sites on the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. Infect Immun 63 (1995) 2846-2853
76. Sartain M.J., and Belisle J.T. N-Terminal clustering of the O-glycosylation sites in the Mycobacterium tuberculosis lipoprotein SodC. Glycobiology 19 (2009) 38-51
77. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M., Engele M., Sieling P., et al. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 291 (2001) 1544-1547
78. Noss E.H., Pai R.K., Sellati T.J., Radolf J.D., Belisle J., Golenbock D.T., et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 167 (2001) 910-918
79. Lopez M., Sly L.M., Luu Y., Young D., Cooper H., and Reiner N.E. The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J Immunol 170 (2003) 2409-2416
80. Espitia C., Espinosa R., Saavedra R., Mancilla R., Romain F., Laqueyrerie A., et al. Antigenic and structural similarities between Mycobacterium tuberculosis 50- to 55-kilodalton and Mycobacterium bovis BCG 45- to 47-kilodalton antigens. Infect Immun 63 (1995) 580-584
81. Nagai S., Wiker H.G., Harboe M., and Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 59 (1991) 372-382
82. Dobos K.M., Khoo K.H., Swiderek K.M., Brennan P.J., and Belisle J.T. Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. J Bacteriol 178 (1996) 2498-2506
83. Jentoft N. Why are proteins O-glycosylated?. Trends Biochem Sci 15 (1990) 291-294
84. Herrmann J.L., O'Gaora P., Gallagher A., Thole J.E., and Young D.B. Bacterial glycoproteins: a link between glycosylation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium tuberculosis. EMBO J 15 (1996) 3547-3554
85. Horn C., Namane A., Pescher P., Riviere M., Romain F., Puzo G., et al. Decreased capacity of recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte responses related to changes in their mannosylation pattern. J Biol Chem 274 (1999) 32023-32030
86. Torrelles J.B., Azad A.K., Henning L.N., Carlson T.K., and Schlesinger L.S. Role of C-type lectins in mycobacterial infections. Curr Drug Targets 9 (2008) 102-112
87. Ehlers S. DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison. Eur J Cell Biol 89 (2010) 95-101
88. Beatty W.L., Rhoades E.R., Ullrich H.J., Chatterjee D., Heuser J.E., and Russell D.G. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1 (2000) 235-247
89. Bhatnagar S., Shinagawa K., Castellino F.J., and Schorey J.S. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 110 (2007) 3234-3244
90. Giri P.K., and Schorey J.S. Exosomes derived from M. bovis BCG infected macrophages activate antigen-specific CD4+ and CD8 + T cells in vitro and in vivo. PLoS One 3 (2008) e2461
91. Cobb B.A., and Kasper D.L. Coming of age: carbohydrates and immunity. Eur J Immunol 35 (2005) 352-356
92. Coyne M.J., Reinap B., Lee M.M., and Comstock L.E. Human symbionts use a host-like pathway for surface fucosylation. Science 307 (2005) 1778-1781
93. Vimr E.R., Kalivoda K.A., Deszo E.L., and Steenbergen S.M. Diversity of microbial sialic acid metabolism. Microbiol Mol Biol Rev 68 (2004) 132-153
94. Munford R.S., and Hall C.L. Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial lipopolysaccharides. J Biol Chem 264 (1989) 15613-15619
95. Kitchens R.L., Ulevitch R.J., and Munford R.S. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med 176 (1992) 485-494
96. Munford R.S., and Hall C.L. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234 (1986) 203-205
97. Luchi M., and Munford R.S. Binding, internalization, and deacylation of bacterial lipopolysaccharide by human neutrophils. J Immunol 151 (1993) 959-969
98. Katz S.S., Weinrauch Y., Munford R.S., Elsbach P., and Weiss J. Deacylation of lipopolysaccharide in whole Escherichia coli during destruction by cellular and extracellular components of a rabbit peritoneal inflammatory exudate. J Biol Chem 274 (1999) 36579-36584
99. Duque-de-Mello M., Ho J.L., Vannier-Santos M.A., and Pimenta P.F.P. Lipophosphoglycan traffic and degradation in Leishmania-infected macrophages. Mem Inst Oswaldo Cruz 94 (1999) 55-99
100. Cobb B.A., Wang Q., Tzianabos A.O., and Kasper D.L. Polysaccharide processing and presentation by the MHCII pathway. Cell 117 (2004) 677-687
101. Prigozy T.I., Naidenko O., Qasba P., Elewaut D., Brossay L., Khurana A., et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 291 (2001) 664-667
102. Kolter T., and Sandhoff K. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu Rev Cell Dev Biol 21 (2005) 81-103
103. Wilkening G., Linke T., and Sandhoff K. Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. J Biol Chem 273 (1998) 30271-30278
104. Moody D.B., Reinhold B.B., Reinhold V.N., Besra G.S., and Porcelli S.A. Uptake and processing of glycosylated mycolates for presentation to CD1b-restricted T cells. Immunol Lett 65 (1999) 85-91
105. Moody D.B., Guy M.R., Grant E., Cheng T.Y., Brenner M.B., Besra G.S., et al. CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med 192 (2000) 965-976
106. Kaur D., Guerin M.E., Škovierová H., Brennan P.J., and Jackson M. Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis. In: Laskin A.I., Sariaslani S., and Gadd G.M. (Eds). Advances in applied microbiology (2009), Acedemic Press, Burlington, US 23-78 Year book
107. Torrelles J.B., Desjardin L.E., MacNeil J., Kaufman T.M., Kutzbach B., Knaup R., et al. Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death. Glycobiology 19 (2009) 743-755
108. McCarthy T.R., Torrelles J.B., Macfarlane A.S., Katawczik M., Kutzbach B., Desjardin L.E., et al. Overexpression of Mycobacterium tuberculosis manB, a phosphomannomutase that increases phosphatidylinositol mannoside biosynthesis in Mycobacterium smegmatis and mycobacterial association with human macrophages. Mol Microbiol 58 (2005) 774-790
109. Patterson J.H., Waller R.F., Jeevarajah D., Billman-Jacobe H., and McConville M.J. Mannose metabolism is required for mycobacterial growth. Biochem J 372 (2003) 77-86
110. Dinadayala P., Kaur D., Berg S., Amin A.G., Vissa V.D., Chatterjee D., et al. Genetic basis for the synthesis of the immunomodulatory mannose caps of lippoarabinomannan in Mycobacterium tuberculosis. J Biol Chem 281 (2006) 20027-20035
111. Appelmelk B.J., den D.J., Driessen N.N., Ummels R., Pak M., Nigou J., et al. The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol 10 (2008) 930-944
112. Torrelles J.B., Knaup R., Kolareth A., Slepushkina T., Kaufman T.M., Kang P.B., et al. Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. J Biol Chem 283 (2008) 31417-31428
113. Martinez-Pomares L., Linehan S.A., Taylor P.R., and Gordon S. Binding properties of the mannose receptor. Immunobiology 204 (2001) 527-535
114. Gutacker M.M., Mathema B., Soini H., Shashkina E., Kreiswirth B.N., Graviss E.A., et al. Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J Infect Dis 193 (2006) 121-128
115. Gagneux S., and Small P.M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 7 (2007) 328-337
116. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/B. Proc Natl Acad Sci USA 98 (2001) 5752-5757
117. Tsenova L., Ellison E., Harbacheuski R., Moreira A.L., Kurepina N., Reed M.B., et al. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis 192 (2005) 98-106
118. Ordway D., Henao-Tamayo M., Harton M., Palanisamy G., Troudt J., Shanley C., et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J Immunol 179 (2007) 522-531
119. Tsenova L., Harbacheuski R., Sung N., Ellison E., Fallows D., and Kaplan G. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 25 (2007) 5126-5132
120. Sreevatsan S., Pan X., Stockbauer K.E., Connell N.D., Kreiswirth B.N., Whittam T.S., et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA 94 (1997) 9869-9874
121. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431 (2004) 84-87
122. Reed M.B., Gagneux S., Deriemer K., Small P.M., and Barry III C.E. The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol 189 (2007) 2583-2589
123. VanderVen B.C., Harder J.D., Crick D.C., and Belisle J.T. Export-mediated assembly of mycobacterial glycoproteins parallels eukaryotic pathways. Science 309 (2005) 941-943
124. Jackson M., and Brennan P.J. Polymethylated polysaccharides from Mycobacterium species revisited. J Biol Chem 284 (2009) 1949-1953
125. Lee Y.C., and Ballou C.E. 6-O-methyl-d-glucose from mycobacteria. J Biol Chem 239 (1964) C3602-C3603
126. Lee Y.C. Isolation and characterization of lipopolysaccharides containing 6-O-methyl-d-glucose from Mycobacterium species. J Biol Chem 241 (1966) 1899-1908